BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 34251458)

  • 21. Second-line systemic therapy for metastatic colorectal cancer.
    Mocellin S; Baretta Z; Roqué I Figuls M; Solà I; Martin-Richard M; Hallum S; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006875. PubMed ID: 28128439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of MyFORTA: An Automated Tool to Improve Medications in Older People Based on the FORTA List.
    Wehling M; Weindrich J; Weiss C; Heser K; Pabst A; Luppa M; Bickel H; Weyerer S; Pentzek M; König HH; Lühmann D; van der Leeden C; Scherer M; Riedel-Heller SG; Wagner M; Pazan F
    Drugs Aging; 2024 Jun; 41(6):555-564. PubMed ID: 38848020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive Validity of the Beers and Screening Tool of Older Persons' Potentially Inappropriate Prescriptions (STOPP) Criteria to Detect Adverse Drug Events, Hospitalizations, and Emergency Department Visits in the United States.
    Brown JD; Hutchison LC; Li C; Painter JT; Martin BC
    J Am Geriatr Soc; 2016 Jan; 64(1):22-30. PubMed ID: 26782849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre, prospective study.
    Fahrni ML; Azmy MT; Usir E; Aziz NA; Hassan Y
    PLoS One; 2019; 14(7):e0219898. PubMed ID: 31348784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer.
    Tong L; Ahn C; Symanski E; Lai D; Du XL
    Ann Oncol; 2014 Jun; 25(6):1234-42. PubMed ID: 24681607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol.
    Lavan AH; O'Mahony D; Gallagher P; Fordham R; Flanagan E; Dahly D; Byrne S; Petrovic M; Gudmundsson A; Samuelsson O; Cherubini A; J Cruz-Jentoft A; Soiza RL; Eustace JA
    BMC Geriatr; 2019 Feb; 19(1):40. PubMed ID: 30760204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking and survival of colorectal cancer patients: population-based study from Germany.
    Walter V; Jansen L; Hoffmeister M; Ulrich A; Chang-Claude J; Brenner H
    Int J Cancer; 2015 Sep; 137(6):1433-45. PubMed ID: 25758762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentially Inappropriate Medications and the Time to Full Functional Recovery After Hip Fracture.
    Iaboni A; Rawson K; Burkett C; Lenze EJ; Flint AJ
    Drugs Aging; 2017 Sep; 34(9):723-728. PubMed ID: 28776209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking Behavior and Prognosis After Colorectal Cancer Diagnosis: A Pooled Analysis of 11 Studies.
    Alwers E; Carr PR; Banbury B; Walter V; Chang-Claude J; Jansen L; Drew DA; Giovannucci E; Nan H; Berndt SI; Huang WY; Prizment A; Hayes RB; Sakoda LC; White E; Labadie J; Slattery M; Schoen RE; Diergaarde B; van Guelpen B; Campbell PT; Peters U; Chan AT; Newcomb PA; Hoffmeister M; Brenner H
    JNCI Cancer Spectr; 2021 Oct; 5(5):. PubMed ID: 34738070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival.
    Salimzadeh H; Lindskog EB; Gustavsson B; Wettergren Y; Ljungman D
    BMC Cancer; 2020 May; 20(1):409. PubMed ID: 32397974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excess body weight and colorectal cancer survival: the multiethnic cohort.
    Maskarinec G; Harmon BE; Little MA; Ollberding NJ; Kolonel LN; Henderson BE; Le Marchand L; Wilkens LR
    Cancer Causes Control; 2015 Dec; 26(12):1709-18. PubMed ID: 26358830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
    Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
    Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review.
    Cooper JA; Cadogan CA; Patterson SM; Kerse N; Bradley MC; Ryan C; Hughes CM
    BMJ Open; 2015 Dec; 5(12):e009235. PubMed ID: 26656020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
    Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
    JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimorbidity patterns in chronic older patients, potentially inappropriate prescribing and adverse drug reactions: protocol of the multicentre prospective cohort study MoPIM.
    Baré M; Herranz S; Jordana R; Gorgas MQ; Ortonobes S; Sevilla D; De Jaime E; Ibarra O; Martín C;
    BMJ Open; 2020 Jan; 10(1):e033322. PubMed ID: 31988230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computed Tomography-Based Body Composition Is Not Consistently Associated with Outcome in Older Patients with Colorectal Cancer.
    Looijaard SMLM; Meskers CGM; Slee-Valentijn MS; Bouman DE; Wymenga ANM; Klaase JM; Maier AB
    Oncologist; 2020 Mar; 25(3):e492-e501. PubMed ID: 32162794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic methylation variations predict the susceptibility of six chemotherapy related adverse effects and cancer development for Chinese colorectal cancer patients.
    Li M; Sun X; Yao H; Chen W; Zhang F; Gao S; Zou X; Chen J; Qiu S; Wei H; Hu Z; Chen W
    Toxicol Appl Pharmacol; 2021 Sep; 427():115657. PubMed ID: 34332992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentially inappropriate medication use among geriatric patients in primary care setting: A cross-sectional study using the Beers, STOPP, FORTA and MAI criteria.
    Awad A; Hanna O
    PLoS One; 2019; 14(6):e0218174. PubMed ID: 31194800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network.
    Burnett-Hartman AN; Powers JD; Chubak J; Corley DA; Ghai NR; McMullen CK; Pawloski PA; Sterrett AT; Feigelson HS
    Cancer Causes Control; 2019 Jul; 30(7):747-755. PubMed ID: 31102084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Exercise on Physical Function and Psychological Well-being in Older Patients With Colorectal Cancer Receiving Chemotherapy-A Systematic Review.
    Lund CM; Dolin TG; Mikkelsen MK; Juhl CB; Vinther A; Nielsen DL
    Clin Colorectal Cancer; 2020 Dec; 19(4):e243-e257. PubMed ID: 32828706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.